Brought to you by 
Digene withdraws registration for follow-on
30 Mar 2001
Executive Summary
Digene Corp. (DNA diagnostics) withdrew its proposed follow-on offering because of market conditions; during the five weeks between registration and withdrawal, the share price had fallen along with most technology stocks, losing about 60%.
Deal Industry
- In Vitro Diagnostics
-
In Vitro Diagnostics
- Molecular Diagnostics & Genetic Testing
-
Biotechnology
-
Drug Discovery Tools
- Genomics-Proteomics
-
Drug Discovery Tools
Deal Status
- Withdrawn
Deal Type
-
Financing
- FOPO
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com